• AB Science Presents Supportive Data from its Phase 3 Study in Severe Systemic Mastocytosis at the 22nd Congress of the European Hematology Association (EHA)

    Source: Nasdaq GlobeNewswire / 22 Jun 2017 16:41:40   Europe/London

    N/A
Share on,